FDA approves first m RNA flu vaccine for adults 50+

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

FDA approves first m RNA flu vaccine for adults 50+

The shot, named m Flusiva, is intended for adults age 50 or older.

FDA approves Moderna’s m RNA-based vaccine for the flu

The shot, named m Flusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.

Moderna’s m RNA Flu Vaccine Approved by FDA

The agency requires more data to prove efficacy for over 65s, but has licensed the first m RNA-based flu shot in the United States for those aged 50–64.

Despite RFK Jr.'s Opposition, FDA Approves First m RNA Flu Vaccines

Moderna’s First m RNA Flu Shot Just Won FDA Approval. Now Researchers See Potential for HIV and Malaria

The vaccine could give Moderna a foothold in seasonal flu and strengthen the case for m RNA shots against fast-changing diseases and cancer.

FDA approves Moderna's m RNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses m RNA technology, the drugmaker announced.